NHS in need of more than lip service to quality
This article was originally published in Clinica
The UK government, the medical community and the National Health Service last week issued a report setting out plans to restore confidence in the service by improving quality and safety. It reflects the profession's "growing concerns that recent medical scandals and a handful of problem doctors have tainted [its] reputation".
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.